.
Interested in a Marie S Curie fellowship at Aston? For more information click on this link.

Dr Ian Maidment

Senior Lecturer in Clinical Pharmacy


Pharmacy

School of Life and Health Sciences 
Aston University
Birmingham, 
B4 7ET
UK


Phone Number: 0121 204 3002
Email: i.maidment@aston.ac.uk
Room Number: Room 468


Research Group

Applied Health Research Group

Research Centre

Aston Research Centre for Healthy Ageing (ARCHA)

Ian Maidment
These BBC and ITV media clips feature Ian Maidment being interviewed about a study, which he was involved with as a co-investigator, which linked anti-cholinergic burden with cognitive impairment and mortality.
I joined Pharmacy at Aston in February 2012, having spent the previous 25 years as a practicing pharmacist. I have worked within community, industry, acute hospital and particularly within old age and adult psychiatry where I worked for 18 years; with 9 years at a senior level. In November 2013 I obtained my PhD on – Medication-related adverse events in older people with dementia; causes and possible solutions.

I am an experienced researcher, manager and clinician with a broad research background including working within multi-disciplinary international teams. I am experienced in aspects of management including strategic planning, knowledge management, team development, change management and administration, from both a public sector and commercial environment.

I have taught and developed teaching material for a variety of undergraduate and postgraduate courses. In particular I have developed a Psychopharmacology course for non-medical prescribers and educational material for the College for Postgraduate Pharmacy Education.

MPharm Programme

PH4703: lectures and workshops in clinical pharmacy
PH3601: Workshops in mental health and neurology
PH4704: Lectures on research methods
PH3609: Workshops on medication management in the NHS

OSPAP Programme

PHMRP1 – Programme Director - Pharmacy Practice Research Project

PMHPP4: lectures and workshops in clinical pharmacy

Postgraduate Psychiatric Pharmacy Programme

Lead Course Tutor for postgraduate Certificate, Diploma and MSc.

  • Postgraduate Certificate in Higher Education (distinction), Aston University, 2015
  • PhD entitled - Medication-related adverse events in older people with dementia; causes and possible solutions, Aston University, 2013
  • MA in Health Service Research with Merit, University of Kent, 2010
  • Diploma Management Studies (distinction), Christchurch University, Canterbury, 2004
  • Diploma Psychiatric Pharmacy, De Montfort University, Leicester, 1996
  • BPharm (2:1), University of Bath, 1986
  • 2012 – date: Senior Lecturer in Clinical Pharmacy, Pharmacy, Aston University.
  • 2007 – 2011: Senior Pharmacist / Clinical Lead for R&D, Kent & Medway NHS and Social Care Partnership Trust.
  • 2002 – 2007: Chief Pharmacist for East Kent Partnership NHS Trust.
  • 2000 – 2002: Pharmacy services manager (mental health), Kent & Canterbury Hospital.
  • 1997 – 2000: Mental Health Pharmacist, Norfolk and Waveney Mental Health Trust.
  • 1996 – 1997: Clinical Audit Pharmacist, Royal Berkshire Hospital.
  • 1994 – 1996: Clinical Pharmacist, Thanet Hospital.
  • 1993 – 1994: Locum Pharmacist, St Mary’s Hospital, Isle of Wight.
  • 1988 – 1993: Community Pharmacy Manager.
  • 1987 – 1988: Basic Grade Pharmacist, Lewisham Hospital.
  • 1986 – 1987: Industrial / Hospital Pre-registration Pharmacist.
  • Medication errors in mental health and dementia – widely published in this field and undertaken qualitative and quantitative research. This includes an analysis of all medication errors reported by Mental Health Trusts to the NPSA in a single year, which was part of Themed Review of Medication Safety Incidents (Safety in Doses; NPSA, 2009 – available on
    www.nrls.npsa.nhs.uk/resources/?EntryId45=61625).

  • Medication management in dementia – linked with international leaders in this field. Chair of grant-writing group, which is supported by Dementia and Neurogenerative Diseases (DeNDRoN).

  • Pharmacological interventions for agitation in dementia – co-principal investigator for 1st in world CTIMP (clinical trial of an investigation medicinal product) studying a pharmaceutical agent in dementia. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035185 

  • Anti-cholinergic burden (ACB) – investigator on two recently published trials, which studied the link between ACB, and cognition and mortality (one study, which identified an association between mortality and ACB, received widespread international publicity).
    http://www.ncbi.nlm.nih.gov/pubmed/21926432

    http://www.ncbi.nlm.nih.gov/pubmed/21707557
      

  • Member of the Dementia and Neurogenerative Diseases (DeNDRoN) Dementia Research Network Clinical Studies Group.

  • Member of trial monitoring committee for Drug Safety Research Unit (DSRU) observational trial.
  • 2014 – NIHR (Research for Patient Benefit) - £198,000 – Chief Investigator. Improving the Management of Behaviour that Challenges associated with dementia in Care Homes: protocol for pharmacy-health psychology intervention feasibility study (MEDREV) http://www.aston.ac.uk/medrev/ 
  • 2014 – Pharmacy Research UK - £54,000 – Chief Investigator - A qualitative scoping study exploring the role of the community pharmacist in medication management in people with dementia dwelling in the community.
  • 2014 – Alzheimer’s Society. Pharmacy Lead. ABCD - Anticholinergics, Benzodiazepines, Cognition and Dementia Study. https://www.uea.ac.uk/drug-safety-and-dementia
  • 2014 – NIHR – Mental Health Research Network – £13,000 – Chief Investigator - Study to investigate barriers to recruiting people with mental health problems to clinical trials involving medicinal products. For a copy of the final report see this link.
  • 2006 – 2010: PI with responsibility for medication management in an investigator initiated clinical trial studying memantine in agitation associated with dementia (MAGD; £389,000).
  • 2006 – 2008: Hospital Medicines Management Collaborative – 3rd wave (£30,000).
  • 2004 – 2006: Parkinson’s Disease Society to review the data, and produce a Cochrane review on Parkinson’s Disease Dementia (£5,000).

Currently lead supervisor for 6 experienced mental health pharmacists studying research masters (and supervised one student to completion); both UK based and international (e.g. Sweden, Ireland, Saudi Arabia). Examples of publications from these projects include: 

Prajapati AR, Wilson J, Maidment I Efficacy and safety of second-generation antipsychotic long-acting injections (SGA LAIs) in maintenance treatment of bipolar disorder: protocol for a systematic review and meta-analysis. BMJ Open. 2016. doi: 10.1136/bmjopen-2015-010237. http://bmjopen.bmj.com/content/6/1/e010237.long 

Hynes C, Keating D, McWilliams S, Madigan K, Kinsella A, Maidment I et al. Glasgow Antipsychotic Side-effects Scale for Clozapine - Development and validation of a clozapine-specific side-effects scale. Schizophr Res. 2015. doi: 10.1016/j.schres.2015.07.052. 

Supervised approximately 25 undergraduate research projects. 

In 2014 Mediha Kothari won the College of Mental Health Pharmacy national award for her project which was subsequently published: http://www.aston.ac.uk/news/releases/2014/november-2014/aston-graduate-wins-national-pharmacy-award/ 

Kothari M, Lyon R, Haygarth L. Maidment I. Medicines reconciliation in comparison with NICE guidelines across secondary care mental health organisations. Int J Clin Pharm. 

http://link.springer.com/article/10.1007%2Fs11096-015-0236-7 

In 2015 Samiah Hassan won the College of Mental Health Pharmacy national award for her project investigating the role of community pharmacists in supporting people with mental health problems with their medication.

Possible availability to supervise new suitable applicants in the following areas:

  • Medication management in dementia and mental health.
  • Medication review in the healthcare of older people including dementia and mental health.
  • The impact of anti-cholinergic burden on health outcomes.
  • Interviewed by the Daily Mail in 2013 and 2015 on the risks of polypharmacy and the side-effects of OTC medicines.
  • In 2015 quoted by the Daily Telegraph a new study on a medicine for dementia.
  • 2012: Extensive media coverage including national press (Express and Telegraph) of BMC paper, which suggested that official figures under-estimate the usage of anti-psychotics. 
  • 2011: Two TV (including live interview for BBC news 24), three radio and two press interviews (Daily Telegraph and Daily Mail) and press conference regarding trial published in JAGS linking anti-cholinergic burden with cognitive impairment and mortality. (Story was also widely featured in other media outlets).

  • 2002: Radio broadcast for National Public Radio (USA) on the use of gabapentin as a mood stabilizer.
  • 2011: Member General Pharmaceutical Council.
  • 2011: Founder Member of the Royal Pharmaceutical Society.
  • 2002: Member of the College of Mental Health Pharmacy
  •  On the editorial boards of the Annals of Pharmacotherapy and Kent Journal for Mental Health.
  • Peer reviewer for Annals of Pharmacotherapy, Acta Psychiatrica Scandinavica, Pharmaceutical Journal, Current Medical Research & Opinion, Medical Letter, Drug Safety, European Journal of Paediatric Neurology, Journal of Affective Disorders, Expert Opinion, International Journal for Quality in Health Care, Journal of Mental Health, International Journal of Geriatric Psychiatry, BMC Geriatrics, CNS Drugs and Ageing & Mental Health, International Clinical Psychopharmacology, BMC Health Services Research, International Psychogeriatrics, Cochrane Collaboration. NICE Technology Assessments.
  • Grant reviewer for NIHR RfPB and Applied Programme Grants, and Evaluation, Trials and Studies Coordinating Centre.

Recent Publications